Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

956 evidence items · page 2 / 39

5.5 %Among HIV-negative women, Mycoplasma hominis colonization was identified in 5.5%.

Burkina FasoMycoplasma hominis colonizationpublished 2011Journal of infection in developing countrieseurope_pmcdocument of 12 observationsDOI 10.3855/jidc.950

7 daysTwo mosquito-derived M. pingshaense isolates (Met_S26 and Met_S10) showed an LT80 of ~7 days against Anopheles coluzzii at a spore dosage of 1 × 10^6 conidia/ml.

Burkina Fasopaludismepublished 2018Parasites & vectorseurope_pmcdocument of 3 observationsDOI 10.1186/s13071-018-2796-6

1.16 odds_ratioHigh baseline parasitaemia was associated with an adjusted odds ratio of 1.16 for day 3 positivity per 2-fold increase in parasite density.

Burkina Fasopaludismepublished 2015BMC medicineeurope_pmcdocument of 11 observations

129 mmFollowing paracentesis, the median value of the Ascites Index was 129 mm in patients with ovarian hyperstimulation syndrome.

Burkina Fasoovarian hyperstimulation syndromepublished 2018Journal of ultrasonographyeurope_pmcdocument of 5 observations

405,000 deathsEvery year, malaria kills approximately 405,000 people in Sub-Saharan Africa.

Burkina Fasopaludismepublished 2022Nature communicationseurope_pmcdocument of 5 observationsDOI 10.1038/s41467-022-28419-0

16 %Median HBsAg prevalence was approximately 16% in male blood donors in Burkina Faso.

Burkina Fasohépatite Bpublished 2022Viruseseurope_pmcdocument of 11 observations

50 %The specificity of PCT at 0.5 ng/ml for detection of bacteremia in patients aged ≥ 5 years was 50.0%.

Burkina Fasobacteraemiapublished 2021PLoS neglected tropical diseaseseurope_pmcdocument of 11 observations

13.44 %In the town of Koudougou, 13.44% of respondents reported a very low risk of malaria contamination when living more than 500m from waste.

Burkina FasopaludismeHAL · Unilimdocument of 110 observations

9 signalsNine signals were generated both by proportional reporting ratio and Bayesian Confidence Propagation Neural Network.

Burkina Fasopaludismepublished 2014PloS oneeurope_pmcdocument of 4 observationsDOI 10.1371/journal.pone.0096388

When in mixed infections with allelic family K1, MAD20 could not grow to the same levels as it would alone, suggesting competitive suppression in these mixed infections.

Burkina Fasopaludismepublished 2019Scientific reportseurope_pmcdocument of 4 observationsDOI 10.1038/s41598-018-36493-y

Host age was associated with parasite density, and overall, older patients exhibited lower parasite densities than younger patients.

Burkina Fasopaludismepublished 2019Scientific reportseurope_pmcdocument of 4 observationsDOI 10.1038/s41598-018-36493-y

51.3 %Fever remained unexplained in 87 patients (51.3%) among 306 non-malaria endemic travellers who consulted the French embassy’s Centre Médico-Social in Ouagadougou for fever.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

42.4 %In Burkina Faso, the coverage of seasonal malaria chemoprevention (SMC) was 42.4%.

Burkina FasopaludismeHAL · Unilimdocument of 110 observations

Weekly iron supplementation did not reduce anemia in early pregnancy.

Burkina Fasoanémiepublished 2018The Journal of infectious diseaseseurope_pmcdocument of 7 observations

7.1 %An infection rate of 7.1% (17/238) was found for Human Herpes Virus 6 (HHV-6) in HIV-positive patients in Burkina Faso.

Burkina FasoHuman Herpes Virus 6published 2017Mediterranean journal of hematology and infectious diseaseseurope_pmcdocument of 9 observations

42.6 %The prevalence of Pfdhfr mutation C59R was 42.6% among 101 genotyped samples.

Burkina Fasopaludismeobserved 2010published 2017Malaria journaleurope_pmcdocument of 10 observations

48.5 %At delivery, 48.5% of the enrolled Burkinabe primigravid women tested positive for malaria by PCR.

Burkina Fasopaludismepublished 2025Postpartum cytokine shifts and IL-10–mediated immune suppression in malaria-infected primieurope_pmcDOI 10.1101/2025.05.21.655391

6 %G6PD deficiency prevalence was 6.0% in women in the study population.

Burkina Fasodéficit en G6PDpublished 2014Asian Pacific journal of tropical biomedicineeurope_pmcdocument of 4 observations

87.5 %87.5% of HIV samples from Burkina Faso were identified as HIV-1 subtype A.

Burkina FasoHIV-1 subtype Apublished 1998PubMedOpenAlexdocument of 10 observations

16.3 %Among HIV-positive women, Ureaplasma urealyticum colonization was identified in 16.3%.

Burkina FasoUreaplasma urealyticum colonizationpublished 2011Journal of infection in developing countrieseurope_pmcdocument of 12 observationsDOI 10.3855/jidc.950

12 %Clinical failure with chloroquine (CQ) was 12% (53 of 455) in children aged 6–59 months with uncomplicated malaria in the province of Houet, Burkina Faso.

Burkina Fasopaludismepublished 2002Tropical medicine & international health : TM & IHeurope_pmcdocument of 6 observationsDOI 10.1046/j.1365-3156.2002.00952.x

2 visitsThe median visit number on which RT-PCR was still positive after treatment was 2, with a range of 1 to 5.

Burkina Fasopaludismepublished 2012Tropical medicine & international health : TM & IHeurope_pmcdocument of 6 observations

4.6 %In the 6 months-4 years age group, Plasmodium falciparum prevalence assessed using microscopy was 4.6% in Korogwe, Tanzania.

Burkina Fasopaludismepublished 2017Malaria journaleurope_pmcdocument of 16 observations

42.1 %In Sector 8, the simple malaria morbidity rate among people over 5 years of age was 42.10% in 2023.

Burkina Fasopaludismeobserved 2023HAL · Unilimdocument of 110 observations

14.66 %The prevalence of hepatitis B virus infection in the Boucle du Mouhoun region of Burkina Faso was 14.66%.

Burkina Fasohépatite Bpublished 2018BMC public healtheurope_pmcdocument of 12 observationsDOI 10.1186/s12889-018-5432-7

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.